The University of Nottingham Faculty of Engineering and School of Pharmacy are delighted to announce the award of an MRC Confidence in Concept grant in collaboration with AstraZeneca, Quotient Sciences Ltd and Added Scientific Ltd (a University of Nottingham spinout company) to translate towards clinical applications some of the advances made at Nottingham in the 3D printing of pharmaceutical dosage forms.
The 12-month project aims to demonstrate the ability to manufacture personalised dosage forms in a regulated industrial environment focused on medicines development and clinical trials.
Professors Ricky Wildman and Clive Roberts, who the lead the project, commented:
This project is an exciting opportunity to work with leading industrial partners in clinical trials, additive manufacturing and pharmaceuticals, and is an important step for us in exploring the potential of 3D printing for the improvement of human health and wellbeing through more personalised medicines.”
Read the full story on Added Scientific Ltd news page